healthcare3.07 min read
CRISPR Pioneers Launch Startup for Custom Gene-Editing Treatments
18 hours ago•Source: WIRED
Healthcare News
The latest healthcare stories, summarized by AI
Featured Healthcare Stories
View original source
3.38 min•2 days ago
San Francisco Firefighter Denied Cancer Treatment by Blue Shield, City Seeks Intervention
A retired San Francisco firefighter with stage 4 lung cancer is seeking city intervention after Blue Shield denied his treatment, raising concerns about insurance practices and access to lifesaving care.
More Top Stories
2
Amazon Pharmacy Now Offers Novo Nordisk's Wegovy for Weight Loss
Reuters•2 days ago
3
CRISPR Pioneer Launches Startup to Advance Personalized Gene-Editing Therapies
Fierce Biotech•2 days ago
More Healthcare Stories
Texas Revises Laws to Welcome Foreign-Trained Doctors
Originally Published 2 days ago — by The Texas Tribune
Texas has eased licensing requirements for foreign-trained doctors to address a projected physician shortage, allowing them to practice after supervised work in underserved areas, aiming to increase healthcare access in rural and underserved communities.
Doctors Struggle to Manage Increasing Online Lab Test Results
Originally Published 2 days ago — by statnews.com
An increasing number of patients are ordering their own lab tests online without medical consultation, leading to challenges for doctors in interpreting results and integrating them into care, as patients seek immediate health insights outside traditional medical pathways.
OpenAI Launches ChatGPT for Healthcare to Assist Medical Professionals
Originally Published 3 days ago — by Axios
OpenAI has launched ChatGPT for Healthcare, a new suite of AI tools powered by GPT-5 designed for medical professionals, offering features like patient data review and integration with existing systems, aiming to reduce administrative burdens and support clinical decision-making while emphasizing HIPAA compliance. The tools are already being adopted by major institutions, reflecting the growing use of AI in healthcare to improve efficiency amid ongoing staff shortages.
Krystal Biotech Reports Positive Interim Results for CF Gene Therapy KB407
Originally Published 3 days ago — by Krystal Biotech, Inc
Krystal Biotech announced positive interim results from its Phase 1 trial of KB407, a gene therapy for cystic fibrosis, confirming successful lung delivery and expression of wild-type CFTR protein across diverse patients, paving the way for a larger, repeat-dosing study expected to start in 2026.
CMS Selects New Organ Procurement Provider in South Florida
Originally Published 3 days ago — by Centers for Medicare & Medicaid Services | CMS (.gov)
CMS has approved Nevada Donor Network to take over organ procurement services in South Florida after decertifying the University of Miami's provider due to noncompliance, ensuring continued organ donation and transplantation services during the transition.
Eli Lilly's Zepbound and Taltz Combo Shows Promise for Psoriatic Arthritis and Obesity
Originally Published 3 days ago — by statnews.com
Eli Lilly's drug Zepbound, when combined with its immunology therapy Taltz, showed promise in reducing symptoms of psoriatic arthritis in obese patients, suggesting potential new uses for the weight loss drug, though its impact on prescribing patterns remains uncertain.
Understanding TRICARE Charges and Balance Billing
Originally Published 5 days ago — by TRICARE Newsroom (.mil)
The article explains TRICARE's policies on allowable charges and balance billing, highlighting the differences between network, participating, and nonparticipating providers, and advising beneficiaries on how to avoid overpaying for healthcare services under TRICARE.
Overdose Surge in Flathead County Strains Resources and Families
Originally Published 6 days ago — by Flathead Beacon
The article discusses the rising overdose crisis in Flathead County, Montana, driven by fentanyl and poly-drug use, highlighting personal stories like Riley McConnell's, and emphasizing the need for increased awareness, resources, and community intervention to combat the growing opioid epidemic.
Top Clinical Trials and Results to Watch in Early 2026
Originally Published 6 days ago — by BioPharma Dive
The article previews ten significant clinical trials expected in the first half of 2026, focusing on Eli Lilly's obesity drug retatrutide, Merck's flu antiviral CD388, Regenxbio's gene therapy for Duchenne muscular dystrophy, Novartis' Lp(a) cardiovascular treatment, and other innovative therapies for rare diseases and cardiovascular conditions. Success in these trials could lead to major advancements and market approvals in their respective fields.
AI's Growing Role in Healthcare: What Patients Need to Know
Originally Published 6 days ago — by Axios
Over 40 million Americans use ChatGPT daily for health-related information, seeking help with medical bills, insurance, and symptom management, highlighting a growing reliance on AI in navigating complex healthcare issues, despite concerns about accuracy and safety.